For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Molina Healthcare (MOH - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of MOH and the rest of the Medical group's stocks.
Molina Healthcare is a member of our Medical group, which includes 817 different companies and currently sits at #5 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. MOH is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for MOH's full-year earnings has moved 44.90% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, MOH has gained about 74.86% so far this year. In comparison, Medical companies have returned an average of 4.04%. This means that Molina Healthcare is outperforming the sector as a whole this year.
Looking more specifically, MOH belongs to the Medical - HMOs industry, a group that includes 13 individual stocks and currently sits at #53 in the Zacks Industry Rank. This group has gained an average of 21.01% so far this year, so MOH is performing better in this area.
Investors with an interest in Medical stocks should continue to track MOH. The stock will be looking to continue its solid performance.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Molina Healthcare (MOH - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of MOH and the rest of the Medical group's stocks.
Molina Healthcare is a member of our Medical group, which includes 817 different companies and currently sits at #5 in the Zacks Sector Rank. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. MOH is currently sporting a Zacks Rank of #1 (Strong Buy).
The Zacks Consensus Estimate for MOH's full-year earnings has moved 44.90% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
Based on the latest available data, MOH has gained about 74.86% so far this year. In comparison, Medical companies have returned an average of 4.04%. This means that Molina Healthcare is outperforming the sector as a whole this year.
Looking more specifically, MOH belongs to the Medical - HMOs industry, a group that includes 13 individual stocks and currently sits at #53 in the Zacks Industry Rank. This group has gained an average of 21.01% so far this year, so MOH is performing better in this area.
Investors with an interest in Medical stocks should continue to track MOH. The stock will be looking to continue its solid performance.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MOH - FREE